procarbazine has been researched along with Libman-Sacks Disease in 2 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahn, SA | 1 |
| Deicher, H | 1 |
1 review available for procarbazine and Libman-Sacks Disease
| Article | Year |
|---|---|
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
1 other study available for procarbazine and Libman-Sacks Disease
| Article | Year |
|---|---|
[Immunosuppressive therapy in systemic lupus erythematosus].
Topics: Antibodies, Antinuclear; Autoantibodies; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; E | 1972 |